Mineralys Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-29.2M | $-29.2M | — | $455.0K |
| FY2023 | $-81.2M | $-81.2M | $0 | $5.1M |
| FY2024 | $-166.3M | $-166.4M | $96.0K | $11.3M |
| FY2025 | $-142.4M | $-142.4M | $15.0K | $19.3M |